medigraphic.com
ISSN 1817-5996 (Digital)

2012, Número 19

<< Anterior Siguiente >>

Rev Cub de Reu 2012; 14 (19)


Manifestaciones reumáticas en el curso del síndrome de malabsorción intestinal

Hierro GA, Villa JO, Hano GO, López MAM

Idioma: Español
Referencias bibliográficas: 59
Paginas:
Archivo PDF: 159.90 Kb.


RESUMEN

Las diferentes deficiencias de micronutrientes que se detectan en el síndrome de malabsorción intestinal suelen producir síntomas osteomioarticulares que pueden ser la única expresión clínica del mismo. Esto se debe a la pérdida importante de calcio, magnesio, fósforo, entre otros necesarios para el metabolismo del tejido conectivo. Sin embargo, no pocas veces estos síntomas no se deben solamente a estas carencias, sino también a otras patologías que concomitan con enfermedades que cursan con malabsorción. Se hace referencia en esta revisión a algunas de estas patologías que por su frecuencia en consultas especializadas de reumatología y gastroenterología, deben tenerse presente en tales situaciones.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Berck E, Hanbrick W. Tumor of pancreas. In: Bockus H, editor. Gastroenterology. Philadelphia: Saunders; 1980. p. 1168-86.

  2. Gibson LE, Cooke RE. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics. 1959 Mar;23(3):545-9.

  3. Haworth CS, Selby PL, Webb AK, Dodd ME, Musson H, Mc LNR, et al. Low bone mineral density in adults with cystic fibrosis. Thorax. 1999 Nov;54(11):961-7.

  4. Conway SP, Oldroyd B, Morton A, Truscott JG, Peckham DG. Effect of oral bisphosphonates on bone mineral density and body composition in adult patients with cystic fibrosis: a pilot study. Thorax. 2004 Aug;59(8):699-703.

  5. Bodian M, Sheldon W, Lightwood R. Congenital Hypoplasia of the Exocrine Pancreas. Acta Paediatr. 1964 May;53:282-93.

  6. Delgado M, Gómez C, Cos A, Iglesias C, Fernández M, Castillo R, et al. Evaluación nutricional en pacientes con gastrectomía total. Nutr Hosp. 2002;17:236-9.

  7. Högenauer C, Hammer H. Maldigestion and Malabsorption. In: Feldman M, Friedman L, Sleisenger M, editors. Sleisenger & Fordtran's gastrointestinal and liver disease: pathophysiology, diagnosis, management. 9th ed. Philadelphia: Saunders; 2010. p. 1736-68.

  8. Rafique M, Zia S. Abetalipoproteinemia in a Saudi infant. J Coll Physicians Surg Pak. 2011 Feb;21(2):117-8.

  9. Hentati F, El-Euch G, Bouhlal Y, Amouri R. Ataxia with vitamin E deficiency and abetalipoproteinemia. Handb Clin Neurol. 2012;103:295-305.

  10. Huang LS, Janne PA, de Graaf J, Cooper M, Deckelbaum RJ, Kayden H, et al. Exclusion of linkage between the human apolipoprotein B gene and abetalipoproteinemia. Am J Hum Genet. 1990 Jun;46(6):1141-8.

  11. Levin DM. Celiac disease. N Engl J Med. 2008 Feb 14;358(7):747; author reply 8-9.

  12. Roblin X, Helluwaert F, Bonaz B. Celiac disease must be evaluated in patients with Sjogren syndrome. Arch Intern Med. 2004 Nov 22;164(21):2387.

  13. Kaufmann J, Schneider W, Schmidt W, Gromnica-Ihle E. [Concomitant dermatitis herpetiformis Duhring, arthritis and Sjogren syndrome in a patient with celiac disease]. Z Rheumatol. 1998 Apr;57(2):114-7.

  14. Ben Abdelghani K, Mouelhi L, Hriz A, Hajri S, Najjar T, Mahfoudhi M, et al. Systemic lupus erythematosus and celiac disease. Joint Bone Spine. 2012 Mar;79(2):202-3.

  15. 24. Freeman HJ. Adult celiac disease followed by onset of systemic lupus erythematosus. J Clin Gastroenterol. 2008 Mar;42(3):252-5.

  16. 25. Mirza N, Bonilla E, Phillips PE. Celiac disease in a patient with systemic lupus erythematosus: a case report and review of literature. Clin Rheumatol. 2007 May;26(5):827-8.

  17. 26. Mercie P, Viallard JF, Faure I, Moreau JF, Pellegrin JL, Leng B. [Association of celiac disease and lupus]. Presse Med. 1999 Mar 13;28(10):532.

  18. 27. Delvecchio M, De Bellis A, Francavilla R, Rutigliano V, Predieri B, Indrio F, et al. Anti-pituitary antibodies in children with newly diagnosed celiac disease: a novel finding contributing to linear-growth impairment. Am J Gastroenterol. 2010 Mar;105(3):691-6.

  19. Norris JM, Barriga K, Hoffenberg EJ, Taki I, Miao D, Haas JE, et al. Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. JAMA. 2005 May 18;293(19):2343-51.

  20. Zeglaoui H, Landolsi H, Mankai A, Ghedira I, Bouajina E. Type 1 diabetes mellitus, celiac disease, systemic lupus erythematosus and systemic scleroderma in a 15-year-old girl. Rheumatol Int. 2010 Apr;30(6):793-5.

  21. Malamut G, Cellier C. [Clinical manifestations of adult celiac disease.]. Pathol Biol (Paris). 2011 May 27.

  22. Lucendo Villarin AJ, Martin Plaza J, Comas Redondo C. [Celiac disease in adult patients. A different clinical spectre]. An Med Interna. 2006 Apr;23(4):195-6.

  23. Douglas AP, Booth CC. Jejunal mucosal digestion of gluten peptides in adult coeliac disease. Lancet. 1968 Aug 31;2(7566):491-2.

  24. Mazure R, Vazquez H, Gonzalez D, Mautalen C, Pedreira S, Boerr L, et al. Bone mineral affection in asymptomatic adult patients with celiac disease. Am J Gastroenterol. 1994 Dec;89(12):2130-4.

  25. MacMahon RA, Parker ML, McKinnon MC. Zinc treatment in malabsorption. Med J Aust. 1968 Aug 3;2(5):210-2.

  26. Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis; a pathologic and clinical entity. Am J Med. 1952 Nov;13(5):583-90.

  27. Loftus EV, Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004 May;126(6):1504-17.

  28. Butt MT, Bener A, Al-Kaabi S, Yakoub R. Clinical characteristics of Crohn s disease in Qatar. Saudi Med J. 2005 Nov;26(11):1796-9.

  29. Gutierrez del Rio C, Saro Gismera C, Garcia-Alcalde Fernandez ML, Campoamor Serrano M, Moris de la Tassa J. [Crohn disease: a wide clinical spectrum]. Rev Clin Esp. 2000 Apr;200(4):235.

  30. Repiso A, Alcantara M, Munoz-Rosas C, Rodriguez-Merlo R, Perez-Grueso MJ, Carrobles JM, et al. Extraintestinal manifestations of Crohn's disease: prevalence and related factors. Rev Esp Enferm Dig. 2006 Jul;98(7):510-7.

  31. Su CG, Judge TA, Lichtenstein GR. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Clin North Am. 2002 Mar;31(1):307-27.

  32. Lakatos L, Pandur T, David G, Balogh Z, Kuronya P, Tollas A, et al. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World J Gastroenterol. 2003 Oct;9(10):2300-7.

  33. Veloso FT, Carvalho J, Magro F. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol. 1996 Jul;23(1):29-34.

  34. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore). 1976 Sep;55(5):401-12.

  35. Szczeklik K, Owczarek D, Pytko-Polonczyk J, Kesek B, Mach TH. Proinflammatory cytokines in the saliva of patients with active and non-active Crohn's disease. Pol Arch Med Wewn. 2012 May 25;122(5):200-8.

  36. Mizutani T, Akasaka R, Tomita K, Chiba T. Serial changes of cytokines in Crohn's disease treated with infliximab. Hepatogastroenterology. 2011 Sep-Oct;58(110-111):1523-6.

  37. Strober W, Zhang F, Kitani A, Fuss I, Fichtner-Feigl S. Proinflammatory cytokines underlying the inflammation of Crohn's disease. Curr Opin Gastroenterol. 2010 Jul;26(4):310-7.

  38. Ljuca F, Gegic A, Salkic NN, Pavlovic-Calic N. Circulating cytokines reflect mucosal inflammatory status in patients with Crohn's disease. Dig Dis Sci. 2010 Aug;55(8):2316-26.

  39. Gordon JN, MacDonald TT. Osteopontin: a new addition to the constellation of cytokines which drive T helper cell type 1 responses in Crohn's disease. Gut. 2005 Sep;54(9):1213-5.

  40. 49. Gologan S, Iacob R, Preda C, Vadan R, Cotruta B, Catuneanu AM, et al. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease. J Gastrointestin Liver Dis. 2012 Mar;21(1):39-44.

  41. Bentz S, Hausmann M, Piberger H, Kellermeier S, Paul S, Held L, et al. Clinical relevance of IgG antibodies against food antigens in Crohn's disease: a double-blind cross-over diet intervention study. Digestion. 2010;81(4):252-64.

  42. Louis E, El Ghoul Z, Vermeire S, Dall'Ozzo S, Rutgeerts P, Paintaud G, et al. Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease. Aliment Pharmacol Ther. 2004 Mar 1;19(5):511-9.

  43. Wordsworth P. Arthritis and inflammatory bowel disease. Curr Rheumatol Rep. 2000 Apr;2(2):87-8.

  44. Cabre E. Manifestaciones y Complicaciones Extraintestinales de la Enfermedad Inflamatoria Intestinal. Barcelona.2007. Available from: http://www.faes.es/area_medica/imagenes/publicaciones/Manifestaciones_Extraint_EII_494.pdf.

  45. Orchard TR, Wordsworth BP, Jewell DP. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut. 1998 Mar;42(3):387-91.

  46. Forrest EH, Russell RI. Peripheral arthropathies in inflammatory bowel disease. Gut. 1999 Mar;44(3):439.

  47. Valera J, Morales A. Manifestaciones extraintestinales de la enfermedad de Crohn. Revista Hospital Clínico Universidad de Chile. 2001;12(3):185-91.

  48. Fenollar F, Puechal X, Raoult D. Whipple's disease. N Engl J Med. 2007 Jan 4;356(1):55-66.

  49. Azúa-Romeo J, Yus C, Alfaro J. Enfermedad de Whipple de manifestación exclusivamente intestinal. Presentación de un caso y actualización bibliográfica. Rev Esp Patol. 2002;35(1):107-11.

  50. Gil J, Gil P, Aparicio R, Mayor J. Association between Whipple's disease and Giardia lamblia infection. Rev Esp Enferm Dig. 2005;97(7):521-6.

  51. Reyes R, Peris P, Feu F, Martinez-Ferrer A, Quera A, Guanabens N. [Whipple's disease. Analysis of 6 cases]. Med Clin (Barc). 2008 Feb 23;130(6):219-22.

  52. Altiner A, Mandal R. Behcet syndrome. Dermatol Online J. 2010;16(11):18.

  53. Pozo González A, Barbán Fernández L, Rodríguez del Valle KM, Betancourt Fernández I. Síndrome de Behçet: presentación de un caso. Revista Archivo Médico de Camagüey. 2010;14:1-7.

  54. Álvarez Álvarez G, Martínez Delgado F, González Cortiñas M, Martín García CL, Martínez Fraga A. Enfermedad de Behcet: Informe de 5 casos. Revista Cubana de Medicina. 1998;37:119-22.

  55. Arnold C, Revaz S, Dudler J. [Arthritis, erythema nodosum and genital ulcerations. Behcet disease]. Praxis (Bern 1994). 2011 Apr 13;100(8):483-6.

  56. Sugawara S, Ehara S, Hitachi S, Sugimoto H. Hand and wrist arthritis of Behcet disease: imaging features. Acta Radiol. 2010 Mar;51(2):183-6.

  57. Melikoglu MA, Melikoglu M. The relationship between disease activity and depression in patients with Behcet disease and rheumatoid arthritis. Rheumatol Int. 2010 May;30(7):941-6.

  58. Moll C, Bogas M, Gomez-Puerta JA, Celis R, Vazquez I, Rodriguez F, et al. Macroscopic features of knee synovitis in early untreated Behcet disease and psoriatic arthritis. Clin Rheumatol. 2009 Sep;28(9):1053-7.

  59. Park JH. Clinical analysis of Behcet disease: arthritic manifestations in Behcet disease may present as seronegative rheumatoid arthritis or palindromic rheumatism. Korean J Intern Med. 1999 Jan;14(1):66-72.




2020     |     www.medigraphic.com